Attostat, Inc. has the ability to industrially mass-produce nanoparticles. It uses a one-stop process that includes laser ablation and cross lasers to create nanoparticles. This results in no ions being produced and allows the particles that are created to have long-lasting effects.
AuraSense's uniquely engineered nanoparticles possess unparalleled biocompatibility and versatility as therapeutics and as novel assays within live cells. They hold great promise for combating the most threatening diseases, including heart disease, cancer, and bacterial infection.
Axion is developing advanced energy storage devices that it refers to as e3 Supercells. Axion's e3 Supercells replace the lead-based negative electrodes found in conventional lead-acid batteries with nanoporous carbon electrodes.
A specialty pharmaceutical company with a novel drug delivery system. Its proprietary Protein Stabilized Liposomes nanotechnology platform addresses the significant problems associated with delivery of water insoluble drugs.
Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum – from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing – Beckman Coulter's 200,000 installed systems provide essential biomedical information to enhance health care around the world.